Ibuprofen 400MG/600MG/800MG Tablets

Dept of Defense · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

February 15, 2029
Response Due
Active
Status

Opportunity Overview

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ibuprofen Tablets. Procurement details follow.

Ibuprofen 400MG in 500 count bottles and 100 count boxes, Ibuprofen 600MG in 500 count bottles, and Ibuprofen 800MG in 12, 15, 30, 90, 100 and 500 count bottles and 100 count boxes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Priso

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ibuprofen Tablets. Procurement details follow.

Ibuprofen 400MG in 500 count bottles and 100 count boxes, Ibuprofen 600MG in 500 count bottles, and Ibuprofen 800MG in 12, 15, 30, 90, 100 and 500 count bottles and 100 count boxes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at...

This is one of 124 active United States Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDept of Defense
CountryUnited States
CategoryPharmaceuticals
NAICS325412
PSC6505
PublishedFebruary 15, 2023
Procurement stageRequest for Proposal (RFP)
Response dueFebruary 15, 2029
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

PPVG GEN V Award
National Retardant
PPVG GEN V AWARD SPE2DX25D8000
Febuxostat National Contract
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Olopatadine HCL 0.1% Ophthalmic Solution

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.